首页> 外文期刊>Cancer Management and Research >The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels
【24h】

The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels

机译:血清CEA水平/术前血清CEA水平比值对术前血清CEA水平高的大肠癌患者的预后价值。

获取原文
       

摘要

Purpose: This study aimed to assess the prognostic value of the postoperative serum carcinoembryonic antigen (CEA) levels/preoperative serum CEA levels ratio (CEA ratio) in colorectal cancer (CRC) patients with high preoperative serum CEA levels and to identify the optimal prognostic cutoff value. Patients and methods: The medical records of 187 CRC patients in a single center who underwent surgery between September 2012 and September 2014 were retrospectively reviewed. CEA ratio was defined as the ratio between the postoperative serum CEA and preoperative serum CEA. The optimal cutoff values for the CEA ratio were determined by time-dependent receiver operating characteristic (ROC) curve analyses. The Chi-square test or Fisher’s exact probability test were used to test the correlation between CEA ratio and clinicopathological characteristics. Univariate, multivariate, and subgroup Cox proportional hazards analysis were used to identify independent prognostic factors. Kaplan–Meier method was used for establishing survival curves. Results: The median follow-up time was 62 months (range 3–88 months). The optimal CEA ratio cutoff value closely related to disease-free survival was 0.295. In the Chi-square test, the CEA ratio was associated with pN stage ( p =0.003) and postoperative CEA ( p 0.001). In the multivariate analysis, the CEA ratio was an independent prognostic factor for disease-free survival ( p =0.003, HR 2.300 [95% CI: 1.326–3.988]) and cancer-special survival ( p =0.003, HR 2.525 [95% CI: 1.381–4.614]). The CEA ratio reflected the prognosis of CRC patients more accurately than postoperative CEA levels alone, and the CEA ratio of 0.295 was more likely to reflect the prognosis than other cutoff values. Conclusion: The CEA ratio is a simple and useful tool for further forecasting the prognosis of CRC patients with high preoperative CEA levels and may help develop strategies for the postoperative treatment of CRC patients.
机译:目的:本研究旨在评估术前血清CEA水平高的结直肠癌(CRC)患者的术后血清癌胚抗原(CEA)水平/术前血清CEA水平比(CEA比)的预后价值,并确定最佳的预后临界值值。患者和方法:回顾性分析2012年9月至2014年9月在同一中心接受手术治疗的187例CRC患者的病历。 CEA比定义为术后血清CEA与术前血清CEA之比。通过与时间有关的接收机工作特性(ROC)曲线分析确定CEA比的最佳截止值。卡方检验或费舍尔精确概率检验用于检验CEA比率与临床病理特征之间的相关性。单因素,多因素和亚组Cox比例风险分析用于确定独立的预后因素。 Kaplan–Meier方法用于建立生存曲线。结果:中位随访时间为62个月(3–88个月)。与无病生存密切相关的最佳CEA比率临界值是0.295。在卡方检验中,CEA比率与pN分期(p = 0.003)和术后CEA(p <0.001)相关。在多变量分析中,CEA比率是无病生存(p = 0.003,HR 2.300 [95%CI:1.326–3.988])和癌症特殊生存(p = 0.003,HR 2.525 [95%]的独立预后因素。 CI:1.381–4.614])。 CEA比值比单独的术后CEA水平更准确地反映了CRC患者的预后,而CEA比值为0.295较其他临界值更能反映预后。结论:CEA比率是进一步预测术前CEA水平高的CRC患者预后的简单有用工具,可能有助于制定CRC患者术后治疗的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号